The Latest Breaking News from JPMorgan

Federal investigations into questionable trading practices are on the rise—and the fate of Bill Hwang and his firm, Archegos, may await others in the finance industry.

In its Q1 earnings release, Kymera Therapeutics Inc (NASDAQ:KYMR) announced the selection of the equivalent of 100 mg, in the fed state, as the dose for the Phase 1 patient cohort (Part C). The cohort is expected to enroll up to 20 patients with hidradenitis suppurativa (HS) and atopic dermatitis (AD).  In…

JPMorgan Chase & Co (NYSE:JPM) lost its position as the most senior underwriter for Kingsoft Cloud Holdings Ltd's (NASDAQ:KC) Hong Kong stock offering, Bloomberg reports.  The size of the offering in Hong Kong is relatively small, amounting to ~$100 million. The change came after one of JPMorgan's analysts cut the share-price target for the…

JPMorgan analyst Mark Strouse lowered the price target of three electrical equipment companies. Heading into Q1 prints, Strouse predicts alternative energy demand to remain generally robust, with significant upside to European predictions due to the prolonged energy crisis.

Stock bulls are trying to gain back some of the recent losses as Q1 earnings season gets off to a mixed start. As for the war in Ukraine, President Biden announced another +$800 million in weaponry for Ukraine on Wednesday, following an hour-long phone call with the country’s president, Volodymyr…

Plus: Real Money Columnist Doug Kass's epic rant on bank bulls.

JPMorgan's chief executive is in a prime position to identify emerging economic developments.

The Dow Jones Industrial Average rose, as Twitter stock jumped after Elon Musk offered to buy the company.

"While the geopolitical and macro environment has become more volatile, we are executing the strategy we announced at our recent Investor Day," said CEO Jane Fraser.